Skip to main content
. 2018 Aug 15;7:F1000 Faculty Rev-1295. [Version 1] doi: 10.12688/f1000research.14417.1

Table 2. Clinical subgroups of patients with unilateral and bilateral Ménière’s disease.

Unilateral Ménière’s disease (MD)
Type 1 Sporadic MD (if concurrent migraine, autoimmune disease, or familial MD is observed, patients are out of this subgroup)
Type 2 Delayed MD (hearing loss precedes vertigo attacks in months or years)
Type 3 Familial MD (at least two patients in the first or second degree)
Type 4 Sporadic MD with migraine (temporal relationship not required)
Type 5 Sporadic MD plus an autoimmune disease
Bilateral MD
Type 1 Unilateral hearing loss becomes bilateral
Type 2 Sporadic, simultaneous hearing loss (usually symmetric)
Type 3 Familial MD (most families have bilateral hearing loss, but unilateral and bilateral cases may coexist in the same family)
Type 4 Sporadic MD with migraine
Type 5 Sporadic MD with an autoimmune disease

The temporal course of the hearing profile distinguishes unilateral or bilateral involvement 1921.